2 years ago
IOVA
AnalystsReni BenjaminReni Benjamin's Stock Forecasts
AnalystsReni Benjamin
Analyst Ranking
Bottom 12%
#4617 out of 5191 analysts
Average Return
-0.44%
Win Rate
46%82 out of 178
Risk vs Reward
Poor
Good
Reni Benjamin's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Prelude Therapeutics IncPRLD | +220.40% | $0.70 | $2.23 | 2025-03-11 - 2026-02-13 | Buy |
Ambrx Biopharma IncAMAM | +188.96% | $9.69 | $28.00 | 2023-11-19 - 2024-03-06 | Buy |
Ambrx Biopharma IncAMAM | +160.71% | $10.74 | $28.00 | 2023-09-24 - 2024-03-06 | Buy |
Prelude Therapeutics IncPRLD | +147.50% | $0.90 | $2.23 | 2025-04-28 - 2026-02-13 | Buy |
Spark Therapeutics IncONCE | +145.65% | $45.41 | $111.55 | 2018-11-06 - 2019-11-07 | Strong Buy |
Reni Benjamin Analyst Color
Get additional color on Reni Benjamin's coverage of popular stocks
Reni Benjamin's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Sutro Biopharma IncSTRO | 9 | Buy | $23.00 | +42.33% | Upgrades | a month ago |
Allogene Therapeutics IncALLO | 7 | Buy | $5.00 | +177.78% | Upgrades | a month ago |
Compass Therapeutics IncCMPX | 1 | Buy | $10.00 | +59.24% | Initiates Coverage On | 2 months ago |
Bicycle Therapeutics PLCBCYC | 15 | Buy | $12.00 | +129.01% | Maintains | 4 months ago |
Sana Biotechnology IncSANA | 5 | Buy | $5.00 | +29.87% | Reiterates | 8 months ago |
Kura Oncology IncKURA | 11 | Buy | $28.00 | +236.94% | Reiterates | 8 months ago |
Summit Therapeutics IncSMMT | 4 | Buy | $40.00 | +167.38% | Reiterates | 8 months ago |
Prelude Therapeutics IncPRLD | 5 | Buy | $4.00 | +79.37% | Reiterates | 10 months ago |
Cue Biopharma IncCUE | 4 | Buy | $2.00 | +551.47% | Reiterates | 10 months ago |
Bioatla IncBCAB | 9 | Buy | $1.00 | +566.67% | Maintains | a year ago |
Suro Capital CorpSSSS | 1 | Buy | $8.00 | -15.61% | Maintains | a year ago |
Skyward Specialty Insurance Group IncSKWD | 1 | Buy | $60.00 | +32.60% | Reiterates | a year ago |
Blueprint Medicines CorpBPMC | 20 | Buy | $125.00 | -3.45% | Reiterates | a year ago |
Workday IncWDAY | 1 | Buy | $315.00 | N/A | Reiterates | a year ago |
Steris PLCSTE | 1 | Buy | $265.00 | N/A | Reiterates | a year ago |
Werewolf Therapeutics IncHOWL | 5 | Buy | $4.00 | N/A | Maintains | a year ago |
Lava Therapeutics NvLVTX | 6 | Hold | $6.00 | N/A | Downgrades | a year ago |
Beone Medicines LtdONC | 1 | Buy | $288.00 | N/A | Initiates Coverage On | a year ago |
Iovance Biotherapeutics IncIOVA | 9 | Buy | $23.00 | N/A | Maintains | 2 years ago |
Incyte CorpINCY | 13 | Buy | $93.00 | N/A | Reiterates | 2 years ago |
Ambrx Biopharma IncAMAM | 3 | Buy | $15.00 | N/A | Reiterates | 2 years ago |
Inhibrx IncINBX1 | 5 | Buy | $27.00 | N/A | Reiterates | 2 years ago |
Deciphera Pharmaceuticals IncDCPH | 5 | Buy | $23.00 | N/A | Reiterates | 3 years ago |
Adicet Bio IncACET | 2 | Buy | $304.00 | N/A | Reiterates | 3 years ago |
Cti Biopharma CorpCTIC | 4 | Buy | $9.00 | N/A | Reiterates | 3 years ago |
Seagen IncSGEN | 5 | Buy | $168.00 | N/A | Maintains | 3 years ago |
Spectrum Pharmaceuticals IncSPPI | 3 | Buy | $4.00 | N/A | Reiterates | 3 years ago |
Effector Therapeutics IncEFTR | 5 | Buy | $25.00 | N/A | Maintains | 3 years ago |
Compugen LtdCGEN | 1 | Buy | $4.00 | N/A | Maintains | 4 years ago |
Trillium Therapeutics IncTRIL1 | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Aceragen IncACGN | 1 | Hold | N/A | N/A | Downgrades | 5 years ago |
Constellation Pharmaceuticals IncCNST | 1 | Hold | $36.00 | N/A | Initiates Coverage On | 6 years ago |
Ernexa Therapeutics IncERNA | 2 | Buy | $5.00 | N/A | Maintains | 7 years ago |
Macrogenics IncMGNX | 2 | Hold | N/A | N/A | Upgrades | 7 years ago |
Regenxbio IncRGNX | 2 | Strong Buy | N/A | N/A | Upgrades | 7 years ago |
Cypherpunk Technologies IncCYPH | 2 | Buy | $80.00 | N/A | Maintains | 7 years ago |
Voyager Therapeutics IncVYGR | 2 | Strong Buy | N/A | N/A | Upgrades | 7 years ago |
Spark Therapeutics IncONCE | 1 | Strong Buy | $72.00 | N/A | Upgrades | 7 years ago |
Adverum Biotechnologies IncADVM | 2 | Hold | N/A | N/A | Downgrades | 7 years ago |
Adaptimmune Therapeutics PLCADAPY | 1 | Buy | $16.00 | N/A | Maintains | 7 years ago |
Adma Biologics IncADMA | 2 | Buy | $10.00 | N/A | Maintains | 7 years ago |
Tg Therapeutics IncTGTX | 1 | Buy | $12.00 | N/A | Downgrades | 7 years ago |
Urogen Pharma LtdURGN | 1 | Hold | N/A | N/A | Downgrades | 8 years ago |
Audentes Therapeutics IncBOLD1 | 1 | Hold | N/A | N/A | Initiates Coverage On | 8 years ago |
Juno Therapeutics IncJUNO | 2 | Buy | N/A | N/A | Upgrades | 8 years ago |
Bellicum Pharmaceuticals IncBLCM | 2 | Buy | $180.00 | N/A | Maintains | 9 years ago |
Vivosim Labs IncVIVS | 1 | Buy | $1,200.00 | N/A | Initiates Coverage On | 9 years ago |
Invivo Therapeutics Holdings CorpNVIVQ | 1 | Strong Buy | $243,750.00 | N/A | Initiates Coverage On | 10 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.